nu-derm system normal-dry skin transformation trial is a Kit in the Human Prescription Drug category. It is labeled and distributed by Omp, Inc.. The primary component is .
Product ID | 62032-516_0cdf898a-e571-4ff9-a7ed-dd29eb9cbd09 |
NDC | 62032-516 |
Product Type | Human Prescription Drug |
Proprietary Name | nu-derm system normal-dry skin transformation trial |
Generic Name | Hydroquinone, Octinoxate, And Zinc Oxide |
Dosage Form | Kit |
Marketing Start Date | 2012-11-07 |
Marketing Category | UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER |
Labeler Name | OMP, INC. |
Active Ingredient Strength | 0 |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2012-11-07 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | Unapproved drug other |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2012-11-07 |
SPL SET ID: | 376dd650-fa5f-42a7-b974-6f538a28f7f2 |
Manufacturer | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
62032-522 | NU-DERM SYSTEM NORMAL-DRY SKIN TRANSFORMATION TRIAL | NU-DERM SYSTEM NORMAL-DRY SKIN TRANSFORMATION TRIAL |
62032-532 | NU-DERM system NORMAL-DRY SKIN TRANSFORMATION TRIAL | NU-DERM system NORMAL-DRY SKIN TRANSFORMATION TRIAL |
62032-510 | CONDITION AND ENHANCE SYSTEM | HYDROQUINONE, OCTINOXATE, AND ZINC OXIDE |
62032-516 | nu-derm system normal-dry | Hydroquinone, Octinoxate, and Zinc Oxide |
62032-520 | NU-DERM SYSTEM NORMAL-DRY | Hydroquinone, Octinoxate, and Zinc Oxide |
62032-513 | NU-DERM SYSTEM NORMAL-OILY | Hydroquinone, Octinoxate, and Zinc Oxide |
62032-515 | nu-derm system normal-oily | Hydroquinone, Octinoxate, and Zinc Oxide |